David M. Menke

TL;DR: The clinical efficacy of rituximab therapy in systemic mucosa-associated lymphoid tissue (MALT) lymphoma with both periocular and intraocular involvement is described.

TL;DR: Lower dose RT achieved excellent complete response rates with minimal toxicity, comparable with standard dose RT (30-36 Gy), for gMALT, and incidence and severity of reported toxicities were similar between the 2 groups.

TL;DR: A 78-year-old, female patient was treated for DLBCL of the right breast with cyclophosphamide, doxorubicin, vincristine, and prednisone followed by chest wall/axillary radiation in the early 1980s and had since been in complete remission (CR), in which remission was achieved with lenalidomide-based therapy.

TL;DR: The following is a report of a single pelvic nodule that was determined to be metastatic prostate cancer by endoscopic ultrasound-guided, fine-needle aspiration.

TL;DR: It is suggested that, in the absence of the typical CCND1/IGH@ fusion, this rearrangement promotes MCL pathogenesis by eliminating miRNA interaction elements within the 3' untranslated region (UTR) of the CC ND1 mRNA transcript consequently resulting inCCND1 overexpression.